Skip to content
hvivo-logo
About
Investors
Participate
Contact Us
hvivo-logo

Solutions

Integrated, end-to-end clinical development solutions designed to support every stage of your programme—from early research through to clinical delivery and data generation.
View all

Clinical Solutions

Comprehensive clinical trial delivery across Phase I–III with a focus on quality and efficiency.

View all

Drug Development Consulting

Strategic and scientific expertise to guide development, optimise trial design, and reduce risk.
View all

Human Challenge Solutions

World-leading human challenge models to generate early efficacy data and accelerate decision-making.
View all

Laboratory Solutions

Advanced laboratory services delivering high-quality data across bioanalysis, virology, and biomarkers.
View all

Integrated Solutions

A fully connected, end-to-end platform combining clinical, laboratory, recruitment, and consultancy expertise to deliver seamless, efficient clinical development.
View all

Biobank and Storage Solutions

hVIVO provides secure, HTA‑licensed cryostorage and biobanking services with multi‑temperature storage, 24/7 monitoring, full chain‑of‑custody management, and fast local access for biotech, pharma, and research partners.
View all
Clinical Pharmacology Early Phase Phase I Units Phase II/III Data Management Medical Monitoring Medical Writing Project Management Quality Assurance Recruitment Regulatory Affairs Clinical Trial Sites Biostatistics
Statistics, study design, methodology Clinical Pharmacology, PK/PD and Translational Modelling & Simulation Chemistry, Manufacturing & Controls (CMC) Consulting Non Clinical Development Regulatory Affairs Consultancy Due Diligence Biosample Project management Clinical Trials Legal Services Medical Writing
Virus Production, Characterisation Laboratory Services and Sample Analytics Participant Screening & Recruitment for HCT Human Challenge Unit & Clinical Delivery RSV Model Influenza Model COVID-19 Model HRV Model hMPV model Malaria Model Asthma & COPD
Pre Clinical, PK/PD Studies Assay Development & Validation Scientific Consulting & Regulatory Support Techniques, Technology & Automation Clinical Trial Support & Kit Production Bioanalysis & Characterisation PBMC Processing & Isolation Sample Processing Network Laboratory Accreditations Microbiology Laboratory Immunology Laboratory Molecular Laboratory Virology Laboratory
Speed to Clinic Accelerator Investor Readiness Consulting Integrated Clinical Trial Delivery Translational Consulting Research Human Challenge Model Advantage EU Expansion Strategy Site and Recruitment Solutions
Cryostorage Human Biological Samples

Sectors

Explore how we support pharma, biotech, CROs and start-ups across the clinical development lifecycle. 
View all

Pharma

 Partnering with global pharma to accelerate clinical development and deliver high-quality data. 
View all

Biotech

Supporting biotech companies with flexible, expert-led solutions to advance innovative therapies.
View all

CRO

Collaborating with CROs to extend capabilities and enhance clinical trial delivery.
View all

Start up

Helping start-ups navigate early development with strategic guidance and scalable clinical solutions.
View all

Working with Drug Development Investors

Our consulting team partners with investors to provide independent scientific, clinical, and regulatory insight across the full lifecycle of drug development — helping you assess risk, identify value, and support portfolio success.
View all

Therapeutics

Explore our therapeutic expertise across key disease areas, where our integrated clinical, laboratory, and consultancy capabilities support the development of innovative treatments from early research through to clinical proof-of-concept.

Cardiometabolic Solutions

Expertise in developing therapies for metabolic and cardiovascular conditions, supporting early-phase research through to clinical proof-of-concept. 
View All

Infectious Diseases Solutions

Global leadership in infectious disease research, with specialist models and expertise to accelerate vaccine and therapeutic development.
View all

Respiratory Solutions

Deep expertise in respiratory diseases, including asthma and viral infections, supported by advanced clinical and challenge capabilities.
View all

Renal & Hepatic Solutions

Focused support for kidney and liver disease programmes, combining clinical insight with specialist development and trial expertise.
View all

Hemostaseology Solutions

hVIVO, through its CRS network, is dedicated to advancing knowledge of blood clotting disorders and enhancing treatment options for patients around the world — combining decades of specialist experience with rigorous clinical trial infrastructure.
View all

Women's Health Solutions

hVIVO is a specialist in women's health clinical studies, offering a broad spectrum of pharmacodynamic, endocrine, and reproductive assessments across conditions 
View all

Dermatology Solutions

We are dedicated to delivering precise evaluations and compassionate care through specialized expertise, ensuring impactful outcomes in clinical trials and therapeutic development.
View all
PMOS - PCOS Endometriosis

Insights

Access expert insights, upcoming events, and practical workshops from hVIVO, bringing together the latest thinking, research, and real-world expertise across the drug development spectrum, from leading scientific, medical and technical experts
View all

Upcoming Webinars & On Demand Education

Join hVIVO's expert-led webinars to explore the latest advances in clinical development, infectious disease, and human challenge models. 
View all

Scientific Publications

Explore peer-reviewed scientific publications and clinical research papers supported by hVIVO’s scientific, medical, and operational research teams. 
View all

Articles & Resources

Explore the latest insights, research, and expert analysis from hVIVO scientific, medical and technical leaders 
View all
View all

Conferences

Explore the in-person events we’re attending, including key conferences where our team will be exhibiting or visiting. Meet us on the ground, connect face-to-face, and discover how we’re engaging with the latest developments across our industry.
View all

Workshops

Participate in small, interactive workshops designed to provide hands-on insight and practical guidance across key areas of clinical development, led by hVIVO’s subject matter experts.
View all

News & Media

From expert interviews and video features to in-depth editorial contributions, this section brings together our presence in the titles that matter most to the biopharma community. 
View all
🗓️ 12 May | The future of cardiometabolic trials: From obesity to outcomes that matter On Demand | Technical Due Diligence in Drug Development On Demand | Accelerate Your hMPV Programme On Demand | RSV Human Challenge Model
Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults Safety, pharmacokinetics, and pharmacodynamics of sofnobrutinib, a novel non-covalent BTK inhibitor, in healthy subjects: First-in-human phase I study Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study Prophylactic Efficacy of CD388, a Novel Drug–Fc Conjugate, in a Human Influenza A/H3N2 Virus Challenge Model: A Randomized, Controlled Phase 2a Study Human Challenge Trial of a Nucleoside-Modified Messenger Ribonucleic Acid Influenza Vaccine Pre-existing and early cellular immune factors correlate with functionally complete protection against primary controlled human SARS-CoV-2 infection Human SARS-CoV-2 challenge uncovers local and systemic response dynamics Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV Vaccine Changes in memory and cognition during the SARS-CoV-2 human challenge study SARS-CoV-2 human challenge reveals biomarkers that discriminate early and late phases of respiratory viral infections
Redesigning obesity trials for a chronic disease era The Early‑Phase Anchor: Why Medical Monitoring Matters Long Before the First Dose Why Europe Is the Smartest Place to Start Early‑Phase Clinical Development for Early Stage/Emerging Biotechs Paper: Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults What Sponsors Get Wrong About Renal & Hepatic Studies — According to the People Running Them From RSV to hMPV: Building the Next Generation of Respiratory Challenge Models
SaxoCell Conference on Cell and Gene Therapy 11th German Pharm-Tox Summit 2026 BIO International Convention World Vaccine Congress Europe BIO-Europe 2026 Dutch Life Sciences Conference 2026
Workshop: Build Your Target Product Profile With Confidence From Preclinical to Clinical: Essential Steps Toward First-In-Human Studies
Redesigning obesity trials for a chronic disease era The Early‑Phase Anchor: Why Medical Monitoring Matters Long Before the First Dose Why Europe Is the Smartest Place to Start Early‑Phase Clinical Development for Early Stage/Emerging Biotechs Paper: Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults What Sponsors Get Wrong About Renal & Hepatic Studies — According to the People Running Them From RSV to hMPV: Building the Next Generation of Respiratory Challenge Models
hvivo-logo

  • Solutions

    Integrated, end-to-end clinical development solutions designed to support every stage of your programme—from early research through to clinical delivery and data generation.
    View all

  • Sectors

    Explore how we support pharma, biotech, CROs and start-ups across the clinical development lifecycle. 
    View all

  • Therapeutics

    Explore our therapeutic expertise across key disease areas, where our integrated clinical, laboratory, and consultancy capabilities support the development of innovative treatments from early research through to clinical proof-of-concept.

  • Insights

    Access expert insights, upcoming events, and practical workshops from hVIVO, bringing together the latest thinking, research, and real-world expertise across the drug development spectrum, from leading scientific, medical and technical experts
    View all
  • About
  • Investors
  • Participate

    Contact Us
    hvivo-logo-white

    hVIVO Services Limited (“hVIVO”) is registered in England and Wales with registration number 02326557 and registered office at 40 Bank Street, Floor 24, London, E14 5NR.

    Contact Us

    For Investors

    • Results Centre
    • Company Documents
    • Events & Presentations
    • Corporate Governance
    • Share Price Information
    • Environmental, Social & Governance
    • AIM Rule 26
    • Advisors

    About hVIVO

    • About Us
    • One hVIVO
    • Partnerships
    • Board of Directors
    • Leadership Team
    • Our Experts
    • Careers

    News & Media

    • Press Kit
    • Media Library
    • Media Coverage

    Subscribe

    Sign up to our emails and follow us on social media to keep up to date with hVIVO.

    © 2026 Copyright hVIVO Services Limited. All rights reserved.

    Privacy Policy Terms of Service Modern Slavery Cookies Settings Legal